Validive

Monopar Drops Lead Candidate after Disappointing Phase III Analysis
BioSpace
Wed, 03/29/23 - 09:51 am
Monopar Therapeutics
clinical trials
Validive
severe oral mucositis
chemotherapy
cancer
Monopar raises IPO Target to $46 Million
CP Wire
Wed, 09/11/19 - 09:57 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs
Monopar raises IPO Target to $46 Million
Wed, 09/11/19 - 09:53 am
Monopar Therapeutics
Validive
severe oral mucositis
oral mucositis
IPOs